From: Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol
Group
N
Not transformed
Mean (SD)
Square root transformed
Placebo
99
2.81 (2.50)
1.51 (0.73)
Melatonin
1.09 (1.18)
0.91 (0.52)
Baseline dose
8.79 (6.50)
2.74 (1.13)